ArticleNature communications2020
Structure of the dopamine D
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.
0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 85 citations in OpenAlex.
- The structure of the dopamine DScience advances · 2026Article
- Involvement of Serotonergic and Dopaminergic Systems inPharmaceuticals (Basel, Switzerland) · 2026Article
- Computational design of constitutively active mutants of Dopamine D2 receptor inspired by ligand-independent activation mechanisms.BMC biology · 2026Article
- Strategic advances for cryo-EM structural studies of small (<100 kDa) GPCRs.Communications biology · 2026Review
- Design, synthesis, drug-likeness, and molecular dynamics evaluations of monobrominated amathamide G analogs as potential ligands for D2-like dopamine receptors.In silico pharmacology · 2026Article
- Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor.The international journal of neuropsychopharmacology · 2025Article
- Molecular mechanism of human αCommunications biology · 2025Article
- Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine DACS chemical neuroscience · 2025Article
- A tailored database combining reference compound-derived metabolite, metabolism platform and chemical characteristic of Chinese herb followed by activity screening: Application to Magnoliae Officinalis Cortex.Journal of pharmaceutical analysis · 2025Article
- Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.Nature reviews. Drug discovery · 2025Review
- Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: A system pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis.Bioinformatics and biology insights · 2025Article
- Article
- Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity.Biochemical pharmacology · 2024Article
- Neurotransmitter recognition by human vesicular monoamine transporter 2.Nature communications · 2024Article
- A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site.Nature communications · 2024Article
- G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.International journal of molecular sciences · 2024Article
- Unraveling Activation-Related Rearrangements and Intrinsic Divergence from Ligand-Specific Conformational Changes of the Dopamine D3 and D2 Receptors.Journal of chemical information and modeling · 2024Review
- Unveiling and validating biomarkers related to the IL-10 family in chronic sinusitis with nasal polyps: insights from transcriptomics and single-cell RNA sequencing analysis.Frontiers in molecular biosciences · 2024Article
- The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models.Current neuropharmacology · 2024Article
- Design and Synthesis of DMolecules (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 5 institutions in 2 countries.
Dohyun ImDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Takaaki FujiwaraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takanori NakaneDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Bunkyo, Tokyo, Japan.ORCID 0000-0003-2697-2767
Yasuaki YamanakaDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tomoko UemuraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Chihiro MoriDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuki ShiimuraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-9752-7399
Kanako Terakado KimuraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hidetsugu AsadaDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-6255-4728
Norimichi NomuraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-6330-2239
Tomoyuki TanakaDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ayumi YamashitaDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Eriko NangoRIKEN SPring-8 Center, Sayo, Hyogo, Japan.
Kensuke TonoJapan Synchrotron Radiation Research Institute, Sayo, Hyogo, Japan.
Francois Marie Ngako KadjiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.ORCID 0000-0002-9187-4584
Junken AokiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.ORCID 0000-0001-9435-1896
So IwataDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. s.iwata@mfour.med.kyoto-u.ac.jp.ORCID 0000-0003-1735-2937
Tatsuro ShimamuraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. t.shimamura@mfour.med.kyoto-u.ac.jp.ORCID 0000-0002-1158-9485
Kyoto University · JPTohoku University · JPJapan Synchrotron Radiation Research Institute · JPKurume University · JPTokyo University of Science · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
In addition to the serotonin 5-HT
Indexed as
AnimalsAntipsychotic AgentsBinding SitesHEK293 CellsHumansLigandsMiceModels, MolecularProtein BindingReceptors, Dopamine D2SpiperoneAntipsychotic AgentsLigandsReceptors, Dopamine D2Spiperone
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.